Tenofovir News and Research

RSS
90% of hepatitis cases, 65% hepatitis deaths preventable by 2030

90% of hepatitis cases, 65% hepatitis deaths preventable by 2030

Tailored adherence strategies needed to engage young African women in consistent PrEP use

Tailored adherence strategies needed to engage young African women in consistent PrEP use

FDA approves two-drug complete regimen for previously untreated HIV-infected adults

FDA approves two-drug complete regimen for previously untreated HIV-infected adults

Antiviral treatment improves survival for kidney transplant recipients infected with HBV or HCV

Antiviral treatment improves survival for kidney transplant recipients infected with HBV or HCV

New clinical trial aims to examine safety and use of two HIV prevention tools

New clinical trial aims to examine safety and use of two HIV prevention tools

MTN launches new study to empower teen girls with choices in HIV prevention

MTN launches new study to empower teen girls with choices in HIV prevention

PrEP shown to be safe and effective for widespread use

PrEP shown to be safe and effective for widespread use

New, sensitive HBV assay may allow earlier detection of hepatocellular carcinoma

New, sensitive HBV assay may allow earlier detection of hepatocellular carcinoma

Study reveals new strategy to prevent mother-to-child transmission of hepatitis B virus

Study reveals new strategy to prevent mother-to-child transmission of hepatitis B virus

NIH launches large study to compare treatments for pregnant women with HIV

NIH launches large study to compare treatments for pregnant women with HIV

New HIV prevention guidelines from Canada released

New HIV prevention guidelines from Canada released

Study: PrEP program for men who have sex with men could lead to long-term cost savings

Study: PrEP program for men who have sex with men could lead to long-term cost savings

HIV pre-exposure prophylaxis (PrEP) could be cost saving for NHS in long run

HIV pre-exposure prophylaxis (PrEP) could be cost saving for NHS in long run

HIV prevention drug to be trialed by Britain's NHS

HIV prevention drug to be trialed by Britain's NHS

UTHealth participates in study to evaluate effectiveness of new injectable HIV medication

UTHealth participates in study to evaluate effectiveness of new injectable HIV medication

CDC guidelines for PrEP use to prevent HIV transmission do not go far enough, UCLA study suggests

CDC guidelines for PrEP use to prevent HIV transmission do not go far enough, UCLA study suggests

First large-scale clinical study of long-acting injectable HIV drug begins

First large-scale clinical study of long-acting injectable HIV drug begins

Added benefit of combination drug for HIV-infected patients not proven

Added benefit of combination drug for HIV-infected patients not proven

Study provides new insights into real-world use of PrEP

Study provides new insights into real-world use of PrEP

Studies shed new light on why young women in South Africa experience high rates of HIV infection

Studies shed new light on why young women in South Africa experience high rates of HIV infection